INdividual Vocational and Educational Support Trial (INVEST) for young people with borderline personality disorder: study protocol for a randomised controlled trial.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read More Add to Saved list
  • Additional Information
    • Source:
      Publisher: BioMed Central Country of Publication: England NLM ID: 101263253 Publication Model: Electronic Cited Medium: Internet ISSN: 1745-6215 (Electronic) Linking ISSN: 17456215 NLM ISO Abbreviation: Trials Subsets: MEDLINE
    • Publication Information:
      Original Publication: [London] : BioMed Central, 2006-
    • Subject Terms:
      Education* ; Employment*; Borderline Personality Disorder/*rehabilitation ; Rehabilitation, Vocational/*methods; Adolescent ; Adult ; Australia ; Borderline Personality Disorder/diagnosis ; Community Mental Health Services ; Cost-Benefit Analysis ; Early Medical Intervention ; Humans ; Outcome Assessment, Health Care ; Quality of Life ; Randomized Controlled Trials as Topic ; Single-Blind Method ; Young Adult
    • Abstract:
      Background: The clinical onset of borderline personality disorder (BPD) usually occurs in young people (aged 12-25 years) and commonly leads to difficulty achieving and maintaining vocational (education and/or employment) engagement. While current psychosocial interventions lead to improvements in psychopathology, they have little effect upon functioning. Individual Placement and Support (IPS) is a client-driven model that assists individuals with severe mental illness to engage with education and/or employment appropriate to their personal goals, and that provides ongoing support to maintain this engagement. The objective of the INdividual Vocational and Educational Support Trial (INVEST) is to evaluate the effectiveness of adding IPS to an evidence-based early intervention programme for BPD, with the aim of improving vocational outcomes.
      Methods/design: INVEST is a single-blind, parallel-groups, randomised controlled trial (RCT). The randomisation is stratified by gender and age and uses random permuted blocks. The interventions are 39 weeks of either IPS, or 'usual vocational services' (UVS). Participants will comprise 108 help-seeking young people (aged 15-25 years) with three or more DSM-5 BPD features and a desire to study or work, recruited from the Helping Young People Early (HYPE) early intervention programme for BPD at Orygen, in Melbourne, Australia. All participants will receive the HYPE intervention. After baseline assessment, staff who are blind to the intervention group allocation will conduct assessments at 13, 26, 39 and 52 weeks. At the 52-week primary endpoint, the primary outcome is the number of days in mainstream education/employment since baseline. Secondary outcomes include the cost-effectiveness of the intervention, quality of life, and BPD severity.
      Discussion: Current treatments for BPD have little impact on vocational outcomes and enduring functional impairment is prevalent among this patient group. IPS is a targeted functional intervention, which has proven effective in improving vocational outcomes for adults and young people with psychotic disorders. This trial will investigate whether IPS is effective for improving vocational (employment and educational) outcomes among young people with subthreshold or full-syndrome BPD.
      Trial Registration: Australian New Zealand Clinical Trials Registry, ID: ACTRN12619001220156 . 13 September 2019.
    • References:
      Schizophr Bull. 2018 Jan 13;44(1):22-31. (PMID: 29036727)
      Psychiatr Serv. 2001 Mar;52(3):313-22. (PMID: 11239097)
      Early Interv Psychiatry. 2011 Aug;5(3):249-53. (PMID: 21521492)
      Early Interv Psychiatry. 2017 Dec;11(6):526-531. (PMID: 27121481)
      Int Clin Psychopharmacol. 2008 Mar;23(2):70-83. (PMID: 18301121)
      Sci Rep. 2020 Jan 23;10(1):1068. (PMID: 31974517)
      J Pers Disord. 2016 Jun;30(3):351-72. (PMID: 26067158)
      Br J Psychiatry. 2008 Dec;193(6):477-84. (PMID: 19043151)
      PLoS One. 2017 Mar 1;12(3):e0171592. (PMID: 28249032)
      Trials. 2015 Oct 21;16:476. (PMID: 26489661)
      Psychol Med. 2015 Aug;45(11):2237-51. (PMID: 25800970)
      J Pers Disord. 2019 Feb;33(1):71-81. (PMID: 30036169)
      Nat Rev Dis Primers. 2018 May 24;4:18029. (PMID: 29795363)
      Assessment. 2017 Jul;24(5):615-631. (PMID: 26676917)
      JAMA Psychiatry. 2017 Apr 1;74(4):319-328. (PMID: 28249086)
      J Pers Disord. 2017 Oct;31(5):590-605. (PMID: 27749187)
      Epidemiol Psychiatr Sci. 2015 Oct;24(5):446-57. (PMID: 25016950)
      Psychiatr Serv. 2014 Jan 1;65(1):16-23. (PMID: 24247197)
      Early Interv Psychiatry. 2019 Aug;13(4):859-866. (PMID: 29888528)
      Aust N Z J Psychiatry. 2006 Nov-Dec;40(11-12):951-62. (PMID: 17054563)
      J Ment Health. 2010 Dec;19(6):483-91. (PMID: 21121821)
      Br J Psychiatry. 2019 Feb;214(2):76-82. (PMID: 30251616)
      Acta Psychiatr Scand. 2020 Mar;141(3):206-220. (PMID: 31733146)
      Early Interv Psychiatry. 2019 Jun;13(3):692-696. (PMID: 29968285)
      Psychiatry Res. 2018 Apr;262:40-45. (PMID: 29407567)
      J Pers Disord. 2009 Aug;23(4):346-56. (PMID: 19663655)
      Patient. 2014;7(1):85-96. (PMID: 24271592)
      Br J Psychiatry. 2016 Jul;209(1):14-22. (PMID: 27103678)
      J Pers Disord. 2006 Jun;20(3):205-17. (PMID: 16776551)
      Br J Psychiatry. 2015 Oct;207(4):351-6. (PMID: 26089306)
      Eur Psychiatry. 2007 Sep;22(6):354-61. (PMID: 17544636)
      BMJ. 2013 Jan 08;346:e7586. (PMID: 23303884)
      World Psychiatry. 2012 Feb;11(1):32-9. (PMID: 22295007)
      BMC Psychiatry. 2018 Jun 19;18(1):202. (PMID: 29914431)
      Eur Psychiatry. 2014 Oct;29(8):490-7. (PMID: 25174269)
      J Pers Disord. 2019 Feb;33(1):82-100. (PMID: 29469667)
      Early Interv Psychiatry. 2019 Aug;13(4):961-968. (PMID: 30019851)
      Soc Psychiatry Psychiatr Epidemiol. 2014 Dec;49(12):2003-11. (PMID: 24791656)
      Psychopathology. 2009;42(1):32-9. (PMID: 19023232)
      World Psychiatry. 2017 Jun;16(2):215-216. (PMID: 28498598)
      Community Ment Health J. 2018 Aug;54(6):831-841. (PMID: 29159496)
      Am J Psychiatry. 2002 Feb;159(2):276-83. (PMID: 11823271)
      J Behav Health Serv Res. 2015 Apr;42(2):206-22. (PMID: 25391357)
      Nature. 2018 Feb 21;554(7693):441-450. (PMID: 29469094)
      Psychiatr Rehabil J. 2009 Spring;32(4):261-8. (PMID: 19346204)
      Am J Psychiatry. 1992 Sep;149(9):1148-56. (PMID: 1386964)
      J Pers Disord. 2003 Feb;17(1):45-59. (PMID: 12659546)
      J Child Psychol Psychiatry. 2008 Sep;49(9):933-41. (PMID: 18665882)
      Arch Gen Psychiatry. 2011 Aug;68(8):827-37. (PMID: 21464343)
      Cochrane Database Syst Rev. 2001;(2):CD003080. (PMID: 11406069)
      PLoS One. 2012;7(5):e36517. (PMID: 22615776)
      Can J Occup Ther. 2010 Dec;77(5):303-14. (PMID: 21268512)
      Lancet Child Adolesc Health. 2018 Mar;2(3):223-228. (PMID: 30169257)
      Asia Pac Psychiatry. 2014 Jun;6(2):115-9. (PMID: 23857720)
      Psychiatr Serv. 2012 Aug;63(8):758-63. (PMID: 22660842)
      Cochrane Database Syst Rev. 2013 Sep 13;(9):CD008297. (PMID: 24030739)
      Aust N Z J Psychiatry. 2013 May;47(5):421-4. (PMID: 23399859)
      Lancet Psychiatry. 2016 Jul;3(7):636-45. (PMID: 27342692)
      Behav Res Ther. 2014 Oct;61:12-22. (PMID: 25113523)
      Psychol Med. 2012 Dec;42(12):2631-40. (PMID: 22565011)
    • Grant Information:
      APP1144022 National Health and Medical Research Council
    • Contributed Indexing:
      Keywords: Adolescents; Borderline personality disorder; Early intervention; Education; Employment; Individual placement and support; Young adults; Youth
    • Publication Date:
      Date Created: 20200628 Date Completed: 20210405 Latest Revision: 20210405
    • Publication Date:
      20231215
    • Accession Number:
      PMC7320570
    • Accession Number:
      10.1186/s13063-020-04471-3
    • Accession Number:
      32591007